In this on-demand webinar, Covance and Emulate present promising new data on the characterization of the Kidney-Chip as a model to study and predict potential drug-drug interactions.
A More Human-Relevant Model
In the pharmaceutical industry, there is a need for more human-relevant preclinical models that can enable a mechanistic understanding of human diseases and drug action.
Organs-on-Chips can help address this need by recreating in vivo-relevant function and key disease phenotypes in a more physiological microenvironment than conventional cell-based models. Covance and Emulate are collaborating to evaluate the Proximal Tubule Kidney-Chip to study transporter-mediated DDIs to fill the gap between current in vitro options and clinical trials.
In this webinar, scientists from Emulate and Covance showcase promising new data on characterization of the Kidney-Chip as a model to study and predict potential drug-drug interactions.